bYoRNA

Bordeaux, France

bYoRNA is cost-efficient, scalable bioproduction of high-quality therapeutic mRNA using eukaryotic cells, particularly recombinant yeast.

$1.8M raised

Jul 2025

Pre-Seed

Top Investors

Polytechnique VenturesIRDI SORIDEC Gestion

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has bYoRNA raised?

bYoRNA has raised $1.8M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.

Who are bYoRNA's investors?

bYoRNA's investors include Polytechnique Ventures, IRDI SORIDEC Gestion.

Where is bYoRNA headquartered?

bYoRNA is headquartered in Bordeaux, France.

What does bYoRNA do?

bYoRNA is cost-efficient, scalable bioproduction of high-quality therapeutic mRNA using eukaryotic cells, particularly recombinant yeast.

What stage is bYoRNA at?

bYoRNA is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 8, 2025.

MLA

"bYoRNA — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/byorna. Accessed June 17, 2026.

APA

VCBacked. (2025). bYoRNA — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/byorna

Wikipedia (cite web)

{{cite web |title=bYoRNA — Funding & Investors |url=https://www.vcbacked.co/company/byorna |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 8, 2025.